We conducted experiments to assess the efficacy of vascular targeting strategies where USMB, radiation and anti-Dll4 treatments were combined to disrupt tumour vasculature and sustain vascular effects in order to maximize overall tumour response (Figure S1B). The gene discussed is DLL4; the disease is neoplasm.